Hair loss can cause prostate cancer? Hair loss and prostate cancer are not related to each other, but why are they linked? Is it true that balding at a young age is less likely to lead to prostate cancer? Or is it true that hair loss increases the risk of prostate cancer? Conventional medicine believes that most hair loss is caused by hair follicles, which can prevent hair growth if they are constantly exposed to too much dihydrotestosterone. Dihydrotestosterone is a chemical secreted by the male hormone. If there is too much dihydrotestosterone in the blood, the hair follicles will shrink and the hair will become thinner and less abundant. The amount of dihydrotestosterone is proportional to the level of testosterone production. High testosterone levels are known to be one of the main culprits of prostate cancer, which means that hair loss increases the risk of prostate cancer. However, studies have yielded inconsistent results, so let’s read the literature and see what we can find out. 1. Annals of Oncology study (2011-02-15): Men who start losing their hair at age 20 are more likely to develop prostate cancer later in life A study published online in the Annals of Oncology shows that men who start losing their hair at age 20 are more likely to develop prostate cancer later in life and therefore may benefit from screening for the disease. Men who start balding at age 20 may have a higher risk of developing prostate cancer in the future. This may mean that men who go bald at a young age could be screened for prostate cancer and thus detect the disease early. The study was published in the February 15, 2011 issue of the French Annals of Oncology. The study was published in the February 15, 2011 issue of Annals of Oncology. The study was conducted by colleagues led by Philippe Giraud since September 2004. Their study included 388 men being treated for prostate cancer and 281 healthy men. The researchers first asked all the men to fill out a questionnaire and answer questions about having prostate cancer, and then asked them to choose from four photos with different levels of baldness that best represented the condition of their hair at ages 20, 30 and 40. The four photos showed normal hair, hair loss on the forehead, hair loss on the top of the head, and hair loss on the forehead and top of the head. The researchers also interviewed the doctors of the prostate cancer patients interviewed and asked them to provide information about the patients, such as the type of disease, age, stage of disease and treatment. The study was conducted over a period of 28 months. The prostate cancer patients ranged in age from 46 to 84 years old. When compared, the researchers found that 37 of the men with prostate cancer began to experience varying degrees of hair loss in their 20s, compared to 14 of the healthy group. Michael, an assistant professor at the University of Montreal, Canada, who participated in the study, said that all of the men who participated in the survey had a history of hair loss. Yassa said that of all the volunteers who participated in the survey, only three were in the third stage of baldness, or hair loss on the top of the head, at age 20, and none were in the fourth stage, or hair loss on both the forehead and the top of the head. But the statistics show that as soon as baldness begins in the 20s, the risk of developing prostate cancer doubles in the future, regardless of the stage. However, those men who started balding in their 30s or 40s did not have a different risk of developing prostate cancer compared to the healthy group. In addition, being younger when you start balding does not mean that you will develop prostate cancer earlier. The French study compared 388 men treated for prostate cancer with 281 healthy men in a control group and found that the rate of hair loss starting in the 20s was twice as high among those with the disease as among healthy men. However, if hair loss began in the 30s or 40s, the risk of prostate cancer did not differ from that of the control group. The study did not find a correlation between early hair loss and early diagnosis of prostate cancer, nor did it find a correlation between the pattern of hair loss and the development of tumors. Philippe? There is no hard evidence that the general population would benefit from screening for prostate cancer,” said Professor Giroux. We need a way to identify men at high risk of the disease so that they can be screened and considered for chemoprevention with anti-androgen drugs like finasteride. hair loss at age 20 may be one of the easily identifiable risk factors, and more work is now needed to confirm this.” The relationship between hair loss and prostate cancer development is not well understood, the researchers said. “Further work should be conducted, carried out at the molecular level and in large populations, to look for the as-yet-unidentified relationship between androgens, early baldness and prostate cancer.” A U.S. research group concluded (reference pending) that men who start balding before the age of 30 are less likely to develop prostate cancer A U.S. research group, which also studied 2,000 men between the ages of 40 and 47, overturned the traditional notion that hair loss increases the risk of prostate disease. They concluded that men who started balding before the age of 30 were 45 percent less likely to develop prostate cancer than men with normal hair. Prostate cancer expert Jonathan White, a member of the research team, said, “At first, the risk of prostate cancer is higher. White said, “At first, the finding was really shocking. But we did find that men who went bald at a young age were 29 to 45 percentage points less likely to develop prostate cancer than those with normal hair.” 3, Journal of Clinical Oncology research (2014-09-15): M-shaped hair loss at age 45 plus moderate top baldness significantly associated with risk of malignant prostate cancer in men U.S. scientists have found that men who go bald at age 45 are more likely to develop “aggressive prostate cancer. The findings were published in the Sept. 15 issue of the Journal of Clinical Oncology. Researchers looked at nearly 40,000 men between the ages of 55 and 74 between 1993 and 2001. Participants answered questions about the extent and type of hair loss they experienced at age 45. During a subsequent follow-up period from 2006 to 2008, researchers found that more than 1,100 of the participants had been diagnosed with prostate cancer, and 600 of them had developed aggressive prostate cancer. The data also showed that about 18 percent of those who admitted to having male-pattern baldness (i.e., severe hair loss around the forehead and crown) at age 45 had a 39 percent higher risk of developing prostate cancer compared with men who did not have baldness. Other types of hair loss, on the other hand, were not associated with aggressive or other types of prostate cancer. ”Predictably, male baldness may play a role in assessing prostate cancer risk in the future.” Michael K. Cook, a researcher at the National Institute who led the study, said. Cook said. Male pattern baldness, a pattern of hair loss from the front hairline and crown of the head, is hair loss from an overproduction of androgens in the body. For some people, hair starts to fall out from the hairline on the left and right sides of the forehead, then leaves a small cluster of hair in the middle of the head. “Testosterone isn’t really necessarily the problem; it’s the skin’s ability to process testosterone that’s key.” Charles K. Ryan, clinical associate professor at the University of California Department of Medicine, said. Dr. Ryan said that current treatments for hair loss are aimed at blocking the effects of testosterone (sometimes called androgens) on the skin, such as finasteride hair growth agents. Figure: Different types of androgenetic alopecia in men (compared to men without alopecia, type M alopecia plus moderate terminal baldness at age 45 (as marked in the red box above) was not associated with the risk of developing total prostate cancer (HR=1,19) or benign prostatic hyperplasia (HR=0,97) in men and was significantly associated with an increased risk of developing malignant prostate cancer (HR=1,39). However, other types of alopecia were not associated with the risk of developing prostate cancer in men. The results of this study suggest that specific types of androgenetic alopecia are significantly associated with an increased risk of malignant prostate cancer in men. There were two qualifiers here: occurrence at age 45 years (time limitation); and M alopecia plus moderate terminal baldness (type limitation). In addition, the results of this study largely demonstrate that there is an overlap in pathophysiological mechanisms between androgenetic alopecia and prostate carcinogenesis.) However, this study has some limitations. First, it relied only on participants’ recollections to determine hair loss levels at age 45, and human memory is sometimes not always accurate. Second, 89 percent of the participants were white, so it’s not clear whether men of other races would also be affected. The researchers say that only a link between male pattern baldness and aggressive prostate cancer has been found, so it does not prove a causal relationship between baldness and. Nonetheless, we recommend closely watching men in their 40s who are losing their hair, as it is likely an advance warning of developing prostate cancer.